Stay updated on Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Sign up to get notified when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.

Latest updates to the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA minor revision label update was added (Revision: v3.3.2) and a previous label (Revision: v3.3.1) was removed; this does not affect study data or record history details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.3.1 was added to the Record History and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse notice from the page, an operational message that does not affect trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedThe new screenshot reflects a minor UI tweak in the header/navigation with no new study data or status changes visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference12%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.